{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:28:02Z","timestamp":1782311282444,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, causing significant morbidity. Despite the dramatic improvement in treatment, many patients do not achieve complete remission, and biomarkers for subclinical disease, flares, and response to treatment are lacking. Neutrophils and neutrophil extracellular traps (NETs) play key roles in the pathogenesis of autoimmune and inflammatory conditions. In this study, we characterized neutrophil enzyme activity and NETs formation in oligoarticular and polyarticular JIA and explored their association with disease activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Neutrophils from 6 healthy controls and 7 patients with oligoarticular and polyarticular JIA were freshly isolated at time of diagnosis and after glucocorticoid intra-articular injection. Enzymatic activity of neutrophil granular enzymes was monitored by colorimetry and PMA-activated NETs formation was assessed using fluorescent microscopy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this pilot and feasibility study, we revealed that NETs were significantly increased in oligoarticular JIA patients at time of diagnosis compared to healthy controls. Anti-inflammatory treatment using intra-articular steroid injection normalized NETs formation in these patients. Correlation between NETs formation and clinical Juvenile Activity Disease Activity Score-10 (cJADAS-10) was linear and significant (<jats:italic>P<\/jats:italic>\u2009=\u20090.007) in oligo but not in poly JIA patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first study exploring the link of NETs formation with oligo and poly JIA activity. We demonstrated a statistically significant linear correlation between cJADAS-10 and NETs formation in oligo but not in poly JIA patients. Hence, we suggest that NETs may reflect clinical disease activity in JIA, and may serve as a putative biomarker. Further work is needed to validate these initial results and determine the dynamics of NETs formation in JIA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03104-9","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:01:35Z","timestamp":1690776095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Neutrophils extracellular traps formation may serve as a biomarker for disease activity in oligoarticular juvenile idiopathic arthritis: a pilot study"],"prefix":"10.1186","volume":"25","author":[{"given":"Merav","family":"Heshin-Bekenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shusterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Fidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Ben-Shahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Shukrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Binenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Elhasid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"5","key":"3104_CR1","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/J.JPEDS.2011.04.012","volume":"159","author":"S Padeh","year":"2011","unstructured":"Padeh S, Pinhas-Hamiel O, Zimmermann-Sloutskis D, Berkun Y. Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation. J Pediatr. 2011;159(5):832-837.e2. https:\/\/doi.org\/10.1016\/J.JPEDS.2011.04.012.","journal-title":"J Pediatr"},{"key":"3104_CR2","unstructured":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 - PubMed. Accessed February 13, 2022. https:\/\/pubmed-ncbi-nlm-nih-gov.ezlibrary.technion.ac.il\/14760812\/."},{"issue":"3","key":"3104_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0049-0172(96)80009-6","volume":"26","author":"KG Oen","year":"1996","unstructured":"Oen KG, Cheang M. Epidemiology of chronic arthritis in childhood. Semin Arthritis Rheum. 1996;26(3):575\u201391. https:\/\/doi.org\/10.1016\/S0049-0172(96)80009-6.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"3104_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1542\/peds.90.6.950","volume":"90","author":"BA Gare","year":"1992","unstructured":"Gare BA, Fasth A. Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5- year prospective population study. Pediatrics. 1992;90(6):950\u20138. https:\/\/doi.org\/10.1542\/peds.90.6.950.","journal-title":"Pediatrics"},{"key":"3104_CR5","unstructured":"Epidemiology of juvenile chronic arthritis in northern Norway: a ten-year retrospective study - PubMed. Accessed February 21, 2022. https:\/\/pubmed.ncbi.nlm.nih.gov\/9543575\/."},{"issue":"1","key":"3104_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/art.30076","volume":"63","author":"A Ravelli","year":"2011","unstructured":"Ravelli A, Varnier GC, Oliveira S, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum. 2011;63(1):267\u201375. https:\/\/doi.org\/10.1002\/art.30076.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3104_CR7","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ART.20945","volume":"52","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Felici E, Magni-Manzoni S, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005;52(3):826\u201332. https:\/\/doi.org\/10.1002\/ART.20945.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3104_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/WSBM.32","volume":"1","author":"SD Kobayashi","year":"2009","unstructured":"Kobayashi SD, DeLeo FR. Role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip Rev Syst Biol Med. 2009;1(3):309\u201333. https:\/\/doi.org\/10.1002\/WSBM.32.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"3104_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/ANNUREV-PATHOL-020712-164023","volume":"9","author":"TN Mayadas","year":"2014","unstructured":"Mayadas TN, Cullere X, Lowell CA. The multifaceted functions of neutrophils. Annu Rev Pathol. 2014;9:181\u2013218. https:\/\/doi.org\/10.1146\/ANNUREV-PATHOL-020712-164023.","journal-title":"Annu Rev Pathol"},{"issue":"5663","key":"3104_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/SCIENCE.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135. https:\/\/doi.org\/10.1126\/SCIENCE.1092385.","journal-title":"Science"},{"issue":"5","key":"3104_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/J.DEVCEL.2018.01.019","volume":"44","author":"G Sollberger","year":"2018","unstructured":"Sollberger G, Tilley DO, Zychlinsky A. Neutrophil extracellular traps: the biology of chromatin externalization. Dev Cell. 2018;44(5):542\u201353. https:\/\/doi.org\/10.1016\/J.DEVCEL.2018.01.019.","journal-title":"Dev Cell"},{"issue":"3","key":"3104_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/NM.4294","volume":"23","author":"SK Jorch","year":"2017","unstructured":"Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23(3):279\u201387. https:\/\/doi.org\/10.1038\/NM.4294.","journal-title":"Nat Med"},{"issue":"9","key":"3104_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/JCM8091325","volume":"8","author":"LJ O\u2019neil","year":"2019","unstructured":"O\u2019neil LJ, Kaplan MJ, Carmona-Rivera C. The role of neutrophils and neutrophil extracellular traps in vascular damage in systemic lupus erythematosus. J Clin Med. 2019;8(9):1325. https:\/\/doi.org\/10.3390\/JCM8091325.","journal-title":"J Clin Med"},{"issue":"1","key":"3104_CR14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/JIMMUNOL.1100450","volume":"187","author":"E Villanueva","year":"2011","unstructured":"Villanueva E, Yalavarthi S, Berthier CC, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187(1):538\u201352. https:\/\/doi.org\/10.4049\/JIMMUNOL.1100450.","journal-title":"J Immunol"},{"key":"3104_CR15","doi-asserted-by":"publisher","unstructured":"Garcia-Romo GS, Caielli S, Vega B, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011;3(73). https:\/\/doi.org\/10.1126\/SCITRANSLMED.3001201\/SUPPL_FILE\/3-73RA20_SM.PDF.","DOI":"10.1126\/SCITRANSLMED.3001201\/SUPPL_FILE\/3-73RA20_SM.PDF"},{"issue":"178","key":"3104_CR16","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5(178):178ra40-178ra40. https:\/\/doi.org\/10.1126\/scitranslmed.3005580.","journal-title":"Sci Transl Med"},{"key":"3104_CR17","doi-asserted-by":"publisher","unstructured":"Bach M, Moon J, Moore R, Pan T, Nelson JL, Lood C. A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients with Rheumatoid Arthritis. Arthritis Rheumatology. Published online July 28, 2019:art.41062. https:\/\/doi.org\/10.1002\/art.41062.","DOI":"10.1002\/art.41062"},{"issue":"7","key":"3104_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/rheumatology\/kez089","volume":"58","author":"F Hattanda","year":"2019","unstructured":"Hattanda F, Nakazawa D, Watanabe-Kusunoki K, et al. The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis. Rheumatology. 2019;58(7):1293\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kez089.","journal-title":"Rheumatology"},{"key":"3104_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","volume":"7","author":"D S\u00f6derberg","year":"2016","unstructured":"S\u00f6derberg D, Segelmark M. Neutrophil extracellular traps in ANCA-Associated vasculitis. Front Immunol. 2016;7:256. https:\/\/doi.org\/10.3389\/fimmu.2016.00256.","journal-title":"Front Immunol"},{"issue":"1","key":"3104_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/J.JCMGH.2021.03.002","volume":"12","author":"B Drury","year":"2021","unstructured":"Drury B, Hardisty G, Gray RD, Ho GT. Neutrophil extracellular traps in inflammatory bowel disease: pathogenic mechanisms and clinical translation. Cell Mol Gastroenterol Hepatol. 2021;12(1):321\u201333. https:\/\/doi.org\/10.1016\/J.JCMGH.2021.03.002.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3104_CR21","doi-asserted-by":"publisher","unstructured":"Giaglis S, Hahn S, Hasler P. \u201cThe net outcome\u201d: are neutrophil extracellular traps of any relevance to the pathophysiology of autoimmune disorders in childhood?. Front Pediatr. 2016;4(SEP). https:\/\/doi.org\/10.3389\/FPED.2016.00097.","DOI":"10.3389\/FPED.2016.00097"},{"key":"3104_CR22","doi-asserted-by":"publisher","unstructured":"Duvvuri B, Pachman LM, Morgan G, et al. Neutrophil Extracellular Traps in Tissue and Periphery in Juvenile Dermatomyositis. Arthritis Rheum. Published online August 12, 2019:art.41078. https:\/\/doi.org\/10.1002\/art.41078.","DOI":"10.1002\/art.41078"},{"issue":"4","key":"3104_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/art.20125","volume":"50","author":"D Foell","year":"2004","unstructured":"Foell D, Wittkowski H, Hammerschmidt I, et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum. 2004;50(4):1286\u201395. https:\/\/doi.org\/10.1002\/art.20125.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"3104_CR24","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1002\/ART.20631","volume":"50","author":"D Foell","year":"2004","unstructured":"Foell D, Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum. 2004;50(12):3762\u201371. https:\/\/doi.org\/10.1002\/ART.20631.","journal-title":"Arthritis Rheum"},{"key":"3104_CR25","doi-asserted-by":"publisher","first-page":"971121","DOI":"10.3389\/FMED.2022.971121","volume":"9","author":"Z Parackova","year":"2022","unstructured":"Parackova Z, Zentsova I, Malcova H, Cebecauerova D, Sediva A, Horvath R. Increased histone citrullination in juvenile idiopathic arthritis. Front Med (Lausanne). 2022;9:971121. https:\/\/doi.org\/10.3389\/FMED.2022.971121.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3104_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/S12969-016-0085-5","volume":"14","author":"A Consolaro","year":"2016","unstructured":"Consolaro A, Giancane G, Schiappapietra B, et al. Clinical outcome measures in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2016;14(1):23. https:\/\/doi.org\/10.1186\/S12969-016-0085-5.","journal-title":"Pediatr Rheumatol Online J"},{"key":"3104_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-5-13","volume":"5","author":"JN Jarvis","year":"2007","unstructured":"Jarvis JN, Jiang K, Petty HR, Centola M. Neutrophils: the forgotten cell in JIA disease pathogenesis. Pediatr Rheumatol Online J. 2007;5:13. https:\/\/doi.org\/10.1186\/1546-0096-5-13.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"3104_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/S13075-021-02483-1","volume":"23","author":"S Arve-Butler","year":"2021","unstructured":"Arve-Butler S, Schmidt T, Mossberg A, et al. Synovial fluid neutrophils in oligoarticular juvenile idiopathic arthritis have an altered phenotype and impaired effector functions. Arthritis Res Ther. 2021;23(1):109. https:\/\/doi.org\/10.1186\/S13075-021-02483-1.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3104_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/ART.41605","volume":"73","author":"M Metzemaekers","year":"2021","unstructured":"Metzemaekers M, Malengier-Devlies B, Yu K, et al. Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype. Arthritis Rheumatol. 2021;73(5):875\u201384. https:\/\/doi.org\/10.1002\/ART.41605.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"3104_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ART.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61(5):658\u201366. https:\/\/doi.org\/10.1002\/ART.24516.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3104_CR31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/ACR.22393","volume":"66","author":"A Consolaro","year":"2014","unstructured":"Consolaro A, Negro G, Chiara Gallo M, et al. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care Res (Hoboken). 2014;66(11):1703\u20139. https:\/\/doi.org\/10.1002\/ACR.22393.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"3104_CR32","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1136\/annrheumdis-2012-201329","volume":"71","author":"J Gerss","year":"2012","unstructured":"Gerss J, Roth J, Holzinger D, et al. Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis. 2012;71(12):1991\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201329.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3104_CR33","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/rheumatology\/ket152","volume":"52","author":"H Moncrieffe","year":"2013","unstructured":"Moncrieffe H, Ursu S, Holzinger D, et al. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8\/14 protein. Rheumatology (Oxford). 2013;52(8):1467\u201376. https:\/\/doi.org\/10.1093\/rheumatology\/ket152.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3104_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/S12969-021-00600-7","volume":"19","author":"M Backlund","year":"2021","unstructured":"Backlund M, Venge P, Berntson L. A cross-sectional cohort study of the activity and turnover of neutrophil granulocytes in juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2021;19(1):102. https:\/\/doi.org\/10.1186\/S12969-021-00600-7.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03104-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03104-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:04:04Z","timestamp":1690776244000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03104-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3104"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03104-9","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants was reviewed and approved by Institutional Review Board, Sourasky Medical Center Tel Aviv, 0502\u201319-TLV. All participants\u2019 parents provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}